Pregnancy drug market to exceed $112 billion by

Selbyville, Delaware, Nov. 02, 2022 (GLOBE NEWSWIRE) —

pregnancy medicine Market value is expected to exceed USD 112 billion by 2032, according to a new research report from Global Market Insights Inc.

Growing awareness about ensuring safe prenatal and postpartum care for pregnant women and child is likely to boost demand for pregnancy medicines. Healthcare brands around the world have endorsed many dietary supplements and raised awareness about the importance of pregnancy care.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/5385

Proven Benefits in Maintaining a Healthy Pregnancy to Support Hormone Uptake

Hormones segment pregnancy drugs market is expected to witness a CAGR of over 13% from 2023 to 2032. Pregnancy hormones such as human placental lactogen (hPL), human chorionic gonadotropin (hCG) hormone, estrogens and progesterone are essential to support healthy pregnancy and embryonic development in women. High levels of estrogen during pregnancy help the uterus and placenta improve vascularization and nutrient transfer. The increasing number of medical professionals prescribing hormones to ensure healthy childbirth will increase the market share.

Browse key industry information spread over 255 pages with 261 tables, figures and graphs of market data from the report, “Pregnancy Drugs Market Analysis Drug Class (Antanaemia, Antacids, Antiallergics, Analgesics, Antimicrobials, Hormones, Laxatives, Vaccines, Nutritional Supplements {Minerals, Omega 3, Folic Acid, Vitamins, Multivitamins}), Stage of Pregnancy ( 1st quarter, 2nd quarter, 3rd quarter), distribution channel (hospital pharmacy, retail pharmacy, online pharmacy), industry analysis report, regional outlook, growth potential, competitive market share and forecast, 2023 -2032″ in detail with the table of contents: https://www.gminsights.com/industry-analysis/pregnancy-medication-market

Increase in episodic health complexities to increase product demand in Q3

The 3rd trimester segment pregnancy drugs market amassed more than 35% revenue share in 2022. The development and maturation of the fetal brain, kidneys and lungs take place in the 3rd trimester, which increases overall nutritional status of pregnant women. mother. Gynecologists prescribe increased consumption of protein and iron supplements to minimize the risk of anemia and ensure the healthy development of the unborn child at this stage. Increasing episodes of heartburn, constipation, and low blood pressure at this stage may boost pregnancy drug sales.

Wide range of products available to support the expansion of online pharmacies

The online pharmacy segment was worth more than USD 5.5 billion in 2022 and is expected to witness a decent growth rate between 2023 and 2032. Online pharmacies offer attractive discounts and ensure the availability of a wide range of products on a single platform. The accelerated inclination of patients to e-commerce sites, particularly due to the pandemic, has contributed to the growth of online pharmacies as a leading distribution channel. The thriving landscape of the e-commerce industry globally will drive the expansion of the segment in the coming years.

A robust economic landscape to drive product demand across North America

The North America pregnancy drugs market held over 38% market share in 2022 and is likely to register sizable gains by 2032. The rising incidence of pregnancy-related complications in the region and growing awareness of pregnancy care could spur regional expansion. Additionally, the streamlined distribution network and rising healthcare expenditures in major economies such as the United States and Canada will lead to lucrative growth for the regional industry.

Request to customize this research report @ https://www.gminsights.com/roc/5385

Technological advances to boost competitive prospects

The major companies participating in the pregnancy drug market are Alkem Laboratories Limited, Piramal Enterprises Limited, F.Hoffman-La Roche Ltd, Pfizer, Dr. Reddy’s Laboratories, Cipla Inc, Alembic Pharmaceuticals Ltd, Lupine Limited, Glenmark Pharmaceuticals Ltd, Viatris Inc ., (Mylan Inc.) and Amgen Inc.

Browse our report store – GMIPulse @ https://www.gminsights.com/gmipulse

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, USA, is a global provider of market research and advisory services, offering syndicated and custom research reports as well as consulting services. growth. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid in strategic decision-making. These comprehensive reports are designed through proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


        

Comments are closed.